CCIA
PTLA

Campbell & Co Investment Adviser’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-32,994
Closed -$895K – 834
2019
Q2 		$895K Buy
+32,994
New +$1.03M 0.41% 35

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Campbell & Co Investment Adviser's PTLA Position: Q3 2019 in Review

Campbell & Co Investment Adviser sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019, closing a stake of 32,994 shares — an estimated $895K sold.

Campbell & Co Investment Adviser first reported a position in PTLA in Q2 2019 and held it in 1 quarter. The position peaked at $895K in Q2 2019. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

  • Campbell & Co Investment Adviser reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 32,994 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $895K.
  • Campbell & Co Investment Adviser first reported a position in Portola Pharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Portola Pharmaceuticals, Inc. position peaked at $895K in Q2 2019.
  • 212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2019, filed 16 Oct 2019.